AURA logo

Aura Biosciences, Inc.

AURA
Healthcare|Biotechnology|US
$6.56
+0.22 (+3.47%)
DCF Value
$0.67
Tangible Book / Share
$3.32
Cash / Share
$3.41

Ownership Breakdown

72.0%
Float
103.7M
Shares Outstanding
74.6M
Float Shares

Major Holders (40)

Combined: 164.8%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Chen YuIndividual9.90%9,533,333May 12, 202613D/G
Adage Capital Management, L.P.IA, PN8.44%9,104,294Aug 12, 202613D/G
Robert AtchinsonHC, IN8.44%9,104,294Aug 12, 202613D/G
Phillip GrossHC, IN8.44%9,104,294Aug 12, 202613D/G
Suvretta Capital Management, LLCIA, OO7.60%4,701,775Aug 13, 202513D/G
Aaron CowenHC, IN7.60%4,701,775Aug 13, 202513D/G
Averill Master Fund, Ltd.Corporation6.60%4,137,797Aug 13, 202513D/G
Frazier Life Sciences Public Fund, L.P.Partnership5.60%5,807,260Aug 14, 202613D/G
FHMLSP, L.P.Partnership5.60%5,807,260Aug 14, 202613D/G
FHMLSP, L.L.C.Other5.60%5,807,260Aug 14, 202613D/G
Forbion Growth III Management B.V.Other5.10%5,248,841Oct 1, 202613D/G
Forbion Growth Opportunities Fund III Cooperatief U.A.Other5.10%5,248,841Oct 1, 202613D/G
ForGrowth III PA B.V.Other5.10%5,248,841Oct 1, 202613D/G
BlackRock, Inc.Holding company5.03%5,219,492Oct 27, 202613D/G
TCG Crossover Fund III, L.P.Partnership5.00%4,766,666May 12, 202613D/G
TCG Crossover GP III, LLCOther5.00%4,766,666May 12, 202613D/G
TCG Crossover Fund II, L.P.Partnership5.00%4,766,667May 12, 202613D/G
TCG Crossover GP II, LLCOther5.00%4,766,667May 12, 202613D/G
Long Focus Capital Management, LLCInvestment adviser4.90%5,119,582Aug 14, 202613D/G
John HelmersIndividual4.90%5,119,582Aug 14, 202613D/G
Long Focus Capital Master, LTD.Non-US institution3.60%1,782,997Jan 3, 202513D/G
Lene SkoleIndividual3.50%1,750,108Nov 14, 202413D/G
Lundbeckfond Invest A/SCorporation3.50%1,750,108Nov 14, 202413D/G
Rajesh Parekh, Ph.D.Individual3.33%2,071,857Feb 17, 202613D/G
Advent Life Sciences Fund I LPPartnership3.26%2,023,857Feb 17, 202613D/G
Advent Life Sciences LLPPartnership3.26%2,023,857Feb 17, 202613D/G
Advent Life Sciences Fund III LPPartnership3.26%2,023,857Feb 17, 202613D/G
Advent-Harrington Impact Fund LPPartnership3.26%2,023,857Feb 17, 202613D/G
ALS III Carry and Co-Invest LPPartnership3.26%2,023,857Feb 17, 202613D/G
Frazier Life Sciences Public Overage Fund, L.P.Partnership1.50%918,510Aug 14, 202513D/G
FHMLSP Overage, L.P.Partnership1.50%918,510Aug 14, 202513D/G
FHMLSP Overage, L.L.C.Other1.50%918,510Aug 14, 202513D/G
Condagua, LLCOther1.40%724,777Jan 3, 202513D/G
Glenn HelmersIndividual1.40%724,777Jan 3, 202513D/G
FHMLS Xii, L.L.C.Other0.80%805,410Aug 14, 202613D/G
Frazier Life Sciences XII, L.P.Partnership0.80%805,410Aug 14, 202613D/G
FHMLS Xii, L.P.Partnership0.80%805,410Aug 14, 202613D/G
FHMLS XI, L.P.Partnership0.30%358,810Aug 14, 202613D/G
FHMLS XI, L.L.C.Other0.30%358,810Aug 14, 202613D/G
Frazier Life Sciences XI, L.P.Partnership0.30%358,810Aug 14, 202613D/G

Insider Trades (100)

Last 4 quarters: 6,212,923 acquired · 7,109,731 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Person JulieChief People OfficerSep 1, 2026AWARD212,389$7.43$1.6MForm 4
Person JulieChief People OfficerSep 1, 2026AWARD107,611——Form 4
Kratz EricaChief Reg. & Quality OfficerSep 1, 2026AWARD199,115$7.43$1.5MForm 4
Kratz EricaChief Reg. & Quality OfficerSep 1, 2026AWARD100,885——Form 4
Hopkins Janet JillChief Medical OfficerSep 1, 2026AWARD58,850——Form 4
Hopkins Janet JillChief Medical OfficerSep 1, 2026AWARD116,150$7.43$863.0KForm 4
Elazzouzi AmySVP, Finance & PAOSep 1, 2026AWARD23,540——Form 4
Elazzouzi AmySVP, Finance & PAOSep 1, 2026AWARD46,460$7.43$345.2KForm 4
Abu-Absi SusanChief Operating OfficerSep 1, 2026AWARD265,487$7.43$2.0MForm 4
Abu-Absi SusanChief Operating OfficerSep 1, 2026AWARD134,513——Form 4
Person JulieAug 12, 2026OTHER0——Form 4
Kratz EricaAug 10, 2026OTHER0——Form 4
Abu-Absi SusanAug 10, 2026OTHER0——Form 4
Bender JeremydirectorJul 7, 2026AWARD60,000$7.03$421.8KForm 4
Bender JeremydirectorJul 7, 2026AWARD30,000——Form 4
Bender JeremyJul 7, 2026OTHER0——Form 4
Kilroy ConorSee RemarksJul 1, 2026AWARD14,858——Form 4
Gibney Anthony SSee RemarksJun 16, 2026SELL12,824$6.42$82.3KForm 4
Bitetti Teresa MariedirectorJun 11, 2026AWARD15,000——Form 4
Bitetti Teresa MariedirectorJun 11, 2026AWARD30,000$6.21$186.3KForm 4
Srivastava SapnadirectorJun 11, 2026AWARD15,000——Form 4
Srivastava SapnadirectorJun 11, 2026AWARD30,000$6.21$186.3KForm 4
Johnson David MichaeldirectorJun 11, 2026AWARD15,000——Form 4
Johnson David MichaeldirectorJun 11, 2026AWARD30,000$6.21$186.3KForm 4
Mattessich Antony C.directorJun 11, 2026AWARD15,000——Form 4
Mattessich Antony C.directorJun 11, 2026AWARD30,000$6.21$186.3KForm 4
Holles Natalie C.director, officer: See RemarksMay 19, 2026AWARD2,169,103$7.39$16.0MForm 4
Holles Natalie C.director, officer: See RemarksMay 19, 2026AWARD553,844——Form 4
Holles Natalie C.director, officer: See RemarksMay 19, 2026AWARD600,118——Form 4
Matrix Capital Management Company, LP10 percent ownerMay 7, 2026SELL6,922,870$5.64$39.0MForm 4
Holles Natalie C.Apr 30, 2026OTHER0——Form 4
Kilroy ConorSee RemarksApr 16, 2026SELL11,738$7.02$82.4KForm 4
Kilroy ConorSee RemarksMar 2, 2026AWARD62,339——Form 4
Kilroy ConorSee RemarksMar 2, 2026AWARD112,661$6.14$691.7KForm 4
Gibney Anthony SSee RemarksMar 2, 2026AWARD71,245——Form 4
Gibney Anthony SSee RemarksMar 2, 2026AWARD128,755$6.14$790.6KForm 4
de los Pinos Elisabetdirector, officer: See RemarksMar 2, 2026AWARD166,000——Form 4
de los Pinos Elisabetdirector, officer: See RemarksMar 2, 2026AWARD249,000$6.14$1.5MForm 4
Plavsic MarkChief Technology OfficerMar 2, 2026AWARD62,339——Form 4
Plavsic MarkChief Technology OfficerMar 2, 2026AWARD112,661$6.14$691.7KForm 4
Hopkins Janet JillChief Medical OfficerMar 2, 2026AWARD89,056——Form 4
Hopkins Janet JillChief Medical OfficerMar 2, 2026AWARD160,944$6.14$988.2KForm 4
Elazzouzi AmySenior Vice President, FinanceMar 2, 2026AWARD44,528——Form 4
Elazzouzi AmySenior Vice President, FinanceMar 2, 2026AWARD80,472$6.14$494.1KForm 4
Kilroy ConorSee RemarksFeb 17, 2026SELL12,079$5.05$61.0KForm 4
Plavsic MarkChief Technology OfficerFeb 17, 2026SELL15,890$5.05$80.2KForm 4
Hopkins Janet JillChief Medical OfficerFeb 17, 2026SELL20,401$5.06$103.2KForm 4
Elazzouzi AmySenior Vice President, FinanceFeb 17, 2026SELL8,549$5.06$43.3KForm 4
de los Pinos Elisabetdirector, officer: See RemarksFeb 17, 2026SELL47,648$5.06$241.1KForm 4
Elazzouzi AmySenior Vice President, FinanceJan 20, 2026SELL1,581$4.86$7.7KForm 4
de los Pinos Elisabetdirector, officer: See RemarksJan 20, 2026SELL16,928$4.86$82.3KForm 4
Hopkins Janet JillChief Medical OfficerNov 17, 2025SELL17,109$5.42$92.7KForm 4
Elazzouzi AmySenior Vice President, FinanceOct 29, 2025SELL896$6.35$5.7KForm 4
de los Pinos Elisabetdirector, officer: See RemarksOct 29, 2025SELL9,049$6.35$57.5KForm 4
Plavsic MarkChief Technology OfficerOct 16, 2025SELL12,169$6.35$77.3KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.2,319$4.25$9.9KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.1,094$3.16$3.5KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.4,744$2.74$13.0KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025SELL7,722$6.70$51.7KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.547$5.21$2.8KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.547$5.48$3.0KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.1,094$5.48$6.0KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.2,554$5.07$12.9KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.547$5.21$2.8KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.2,319$4.25$9.9KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.4,744$2.74$13.0KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.2,554$5.07$12.9KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.547$5.48$3.0KForm 4
Elazzouzi AmySenior Vice President, FinanceAug 18, 2025OPTION EX.1,094$3.16$3.5KForm 4
Srivastava SapnadirectorJun 17, 2025AWARD13,000——Form 4
Srivastava SapnadirectorJun 17, 2025AWARD17,000$6.18$105.1KForm 4
Johnson David MichaeldirectorJun 17, 2025AWARD13,000——Form 4
Johnson David MichaeldirectorJun 17, 2025AWARD17,000$6.18$105.1KForm 4
Mattessich Antony C.directorJun 17, 2025AWARD13,000——Form 4
Mattessich Antony C.directorJun 17, 2025AWARD17,000$6.18$105.1KForm 4
Gibney Anthony SSee RemarksJun 2, 2025AWARD250,000$6.16$1.5MForm 4
Gibney Anthony SSee RemarksJun 2, 2025AWARD150,000——Form 4
de los Pinos Elisabetdirector, officer: See RemarksJun 2, 2025OPTION EX.10,948$5.07$55.5KForm 4
de los Pinos Elisabetdirector, officer: See RemarksJun 2, 2025TAX W/H9,948$6.16$61.3KForm 4
de los Pinos Elisabetdirector, officer: See RemarksJun 2, 2025OPTION EX.10,948$5.07$55.5KForm 4
Johnson David MichaeldirectorMay 16, 2025BUY20,000$4.90$98.0KForm 4
Johnson David MichaeldirectorMay 16, 2025BUY5,000$4.90$24.5KForm 4
Gibney Anthony SSee RemarksMay 16, 2025BUY50,000$4.90$245.0KForm 4
Gibney Anthony SSee RemarksMay 16, 2025SELL1,519$5.15$7.8KForm 4
Gibney Anthony SSee RemarksMay 16, 2025BUY12,500$4.90$61.3KForm 4
Gibney Anthony SSee RemarksMay 13, 2025OTHER0——Form 4
Gibney Anthony SSee RemarksMay 13, 2025OTHER5,000$7.21$36.0KForm 4
Elazzouzi AmySenior Vice President, FinanceApr 16, 2025SELL897$5.49$4.9KForm 4
Kilroy ConorSee RemarksApr 16, 2025SELL7,162$5.49$39.3KForm 4
Bitetti Teresa MariedirectorMar 31, 2025AWARD29,000$5.86$169.9KForm 4
Bitetti Teresa MariedirectorMar 31, 2025AWARD21,000——Form 4
Bitetti Teresa MarieMar 31, 2025OTHER0——Form 4
Plavsic MarkChief Technology OfficerFeb 18, 2025SELL2,151$7.75$16.7KForm 4
Elazzouzi AmySenior Vice President, FinanceFeb 18, 2025SELL1,404$7.75$10.9KForm 4
Hopkins Janet JillChief Medical OfficerFeb 18, 2025SELL2,534$7.75$19.6KForm 4
de los Pinos Elisabetdirector, officer: See RemarksFeb 18, 2025SELL20,221$7.75$156.8KForm 4
de los Pinos Elisabetdirector, officer: See RemarksFeb 3, 2025AWARD194,320——Form 4
de los Pinos Elisabetdirector, officer: See RemarksFeb 3, 2025AWARD255,680$7.68$2.0MForm 4
Plavsic MarkChief Technology OfficerFeb 3, 2025AWARD90,475——Form 4
Plavsic MarkChief Technology OfficerFeb 3, 2025AWARD59,525$7.68$457.2KForm 4